[ad_1]
The head of the COVID department at the Hospital for Infectious Diseases, Assistant Professor Atanas Mangarov, has not been included on the lists of front-line doctors who are ready to be vaccinated against the coronavirus. Before debati.bg, the infectious disease specialist revealed that he has serious reservations about COVID vaccines mainly due to the short period in which they were created.
According to him, the main problem is not in the allergic reactions that occur, such as fever or redness at the injection site.
“Especially with this vaccine from Pfizer and Biontech, foreign RNA is introduced into the body, causing the cells of the person on whom it is placed to start producing coronavirus proteins. Antibodies against them are already being made. Here are two things that are not specified. The first is to what extent the introduction of this strange genetic code has oncogenic potential, that is, to what extent this genetic code can lead to some malignant transformations in the human cell. This is not something that can be clarified in 3-4 months, but it takes years to clarify. The second thing is to what extent these proteins, these proteins that will be introduced into the human cell, can be perceived as foreign antigens and lead to the appearance of autoimmune diseases. most likely this will not happen, but we cannot prove it, it is not something to be tested in a few months, these are the problems with this vaccine that are not specified. What would happen if, say, 70-80% of people were immunized and after a few months or years it turns out that for example 1-2% of those vaccinated have autoimmune diseases or have some type of cancer.
These are things that need to be clarified for much longer, and not a few months, Adjunct Professor Mangarov is categorical.
“As long as the COVID death rate is less than 0.3%, vaccines that are not as well studied should be given to people who are not feeling well, who are healthy, and these vaccines have not been fully tested according to the rules of good medical practice. In practice, this seems a bit rushed. “
It is not yet clear what immunity this vaccine would create.
“On the one hand, they tell us that the virus did not create long-lasting immunity, which I highly doubt, and on the other hand, we make a vaccine where we use virus particles and we wait there to get a stronger, longer-lasting immunity.”
Sofia, Bulgaria
[ad_2]
